Stomato-pharyngology
Online ISSN : 1884-4316
Print ISSN : 0917-5105
ISSN-L : 0917-5105
Original Articles
A clinical study on oropharyngeal cancer
Masashi Okazaki, Takashi Nasu, Shinichi Okazaki, Kuniaki Chida, Daisuke Noda, Shuji Koike, Seiji Kakehata
Author information
Keywords: oropharyngeal cancer, cisplatin, docetaxel, 5-FU, alternation chemoradiotherapy
JOURNAL FREE ACCESS

2016 Volume 29 Issue 1 Pages 121-125

Details
Download PDF (465K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract

　We retrospectively reviewed 26 cases of oropharyngeal cancer from 2003 to 2012. Advanced cases (Stage III and IV) accounted for 81%. Case in which TPF alternation chemoradiotherapy was indicated accounted for 16 of the 26 and the three-year overall survival rate was 75% and 68% in Stage III and IV, respectively. The disease free survival of TPF alternation chemoradiotherapy was 66.7%, and it is acceptable as one of the oropharyngeal cancer treatment methods.

Content from these authors
© 2016 Japan Society of Stomato-pharyngology
Previous article Next article
Favorites & Alerts

Recently viewed articles
Share this page
feedback
 Top